Emerging peptide therapeutics, monoclonal antibodies, precision medicines and novel delivery technologies are expanding what’s possible in veterinary medicine. At the same time, evolving regulatory expectations and increasingly complex analytical requirements are raising the bar for bioanalysis.
Animal health innovation deserves the same scientific rigor, analytical capabilities and quality standards as human drug development. From companion animals to livestock, veterinary medicines improve health, food security and quality of life worldwide.
As these programs become more sophisticated, sponsors need scientific partners with the analytical capabilities, quality systems and regulatory understanding to help move promising therapies forward. Veloxity has intentionally built scientific capabilities, quality systems and thought leadership to better support animal health sponsors throughout development.